AlzeCure Pharma hosts an online event on 23rd October featuring Dr. Rolf Karlsten to discuss ACD440, a non-opioid analgesic for chronic pain, in Phase II trials.

AlzeCure Pharma will host a live event on October 23, featuring Dr. Rolf Karlsten, to discuss ACD440, a novel non-opioid analgesic in phase II trials for chronic neuropathic pain. This topical gel, a TRPV1 antagonist, demonstrated a 50% reduction in pain during trials. The session will cover pain management advancements and include a Q&A about AlzeCure's ongoing drug development for various neurological conditions. The event will be accessible online.

October 10, 2024
3 Articles